Medical devices: classification of the dental sonography device and jaw tracking device. Final rule.
The Food and Drug Administration (FDA) is classifying the dental sonography device into class I, when it is used to monitor temporomandibular joint sounds, and into class II, when it is used to interpret temporomandibular joint sounds for the diagnosis of temporomandibular joint disorders and associated orofacial pain. FDA is classifying the jaw tracking device into class I, when it is used to monitor mandibular jaw positions relative to the maxilla, and into class II, when it is used to interpret mandibular jaw positions relative to the maxilla, for the diagnosis of temporomandibular joint disorders and associated orofacial pain. Elsewhere in this issue of the Federal Register, FDA is announcing the availability of a guidance document that will serve as the special control for this device. FDA is taking this action under the Federal Food, Drug, and Cosmetic Act (the act) as amended by the Medical Device Amendments of 1976 (the 1976 amendments), the Safe Medical Devices Act of 1990 (the SMDA), the Food and Drug Administration Modernization Act of 1997 (FDAMA) and the Medical Device User Fee and Modernization Act of 2002 (MDUFMA).
D001184:Articulation Disorders / Q000175:diagnosis; D003748:Dental Equipment / Q000145:classification*; D019719:Diagnostic Equipment / Q000145:classification; D004869:Equipment Safety / Q000145:classification; D006801:Humans; D007569:Jaw Abnormalities / Q000175:diagnosis; D007883:Legislation, Medical; D013016:Sound; D013018:Sound Spectrography / Q000145:classification / Q000295:instrumentation*; D013704:Temporomandibular Joint; D014481:United States; D014486:United States Food and Drug Administration